TrimTech adds $14m in funding to accelerate neurodegenerative disease treatments (opens in new tab)

TrimTech Therapeutics announced an additional $14 million in seed funding, bringing the round to $47 million (£35 million). The extension was led by Johnson & Johnson Innovation, JJDC, Inc., and BGF, who join existing investors including Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures, Eli Lilly and Company, MP Healthcare Venture Management and Cambridge Enterprise […] The post appeared first on <a href="